我院静脉药物配置中心2012年9月-2014年2月抗肿瘤药不合理医嘱分析

Analysis of Irrational Medical Orders of Antitumor Drugs in PIVAS of Our Hospital during Sept.2010-Feb.2014

目的:为降低临床抗肿瘤药不合理用药发生率提供参考。方法:调取我院静脉药物配置中心超然管理系统中2012年9月-2014年2月抗肿瘤药医嘱,对不合理医嘱进行分析和总结。结果:在审核的51 204条医嘱中,不合理用药为201条,占0.39%;不合理用药主要表现在溶剂选择不当(42.79%)、给药剂量过大或过小(17.91%)、溶剂体积不合理(32.33%)、给药途径错误(3.98%)、给药顺序不合理(2.49%)以及其他方面(0.50%),医嘱修改率分别为97.67%、100%、95.38%、100%、80.00%及100%。结论:通过定期分析、总结,以医师联系单的形式及不合理医嘱的汇总形式与病房沟通,可以加强对抗肿瘤药应用的监督,保障患者用药安全。

OBJECTIVE： To provide reference for reducing the incidence of irrational use of antitumor drugs. METHODS： The irrational medical orders which would be summarized and analyzed were collected from PIVAS detached management system of our hospital from Sept. 2012 to Feb. 2014. RESULTS： Among 51 204 reviewed medical orders, there were 201 irrational medical or- ders, accounting for 0.39%. The irrational drug use was mainly found in improper solvent （42.79%）, high or low drug dosage （17.91%） , improper solvent volume （32.33%） , improper route of administration （3.98%） , improper route of administration （2.49%） and other problems （0.50%）. The rates of medical order modification were 97.67%, 100%, 95.38%, 100%, 80.00% and 100%, respectively. CONCLUSIONS： Through regular analysis and summary, pharmacists can strengthen the supervision to the rational use of antitumor drugs and guarantee patient safety by communicating with wards using physician communication list and irrational medical order summary.